RU2019126497A - Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества - Google Patents

Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества Download PDF

Info

Publication number
RU2019126497A
RU2019126497A RU2019126497A RU2019126497A RU2019126497A RU 2019126497 A RU2019126497 A RU 2019126497A RU 2019126497 A RU2019126497 A RU 2019126497A RU 2019126497 A RU2019126497 A RU 2019126497A RU 2019126497 A RU2019126497 A RU 2019126497A
Authority
RU
Russia
Prior art keywords
bioadhesive
fibers
drug
hydrophilic polymer
peo
Prior art date
Application number
RU2019126497A
Other languages
English (en)
Russian (ru)
Other versions
RU2019126497A3 (cg-RX-API-DMAC7.html
Inventor
Йенс ХАНСЕН
Original Assignee
Афикс Терапьютикс А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Афикс Терапьютикс А/С filed Critical Афикс Терапьютикс А/С
Publication of RU2019126497A publication Critical patent/RU2019126497A/ru
Publication of RU2019126497A3 publication Critical patent/RU2019126497A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0015Electro-spinning characterised by the initial state of the material
    • D01D5/003Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/16Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of unsaturated carboxylic acids or unsaturated organic esters, e.g. polyacrylic esters, polyvinyl acetate
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/26Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from other polymers
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/62Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
    • D01F6/625Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters derived from hydroxy-carboxylic acids, e.g. lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04Homopolymers or copolymers of esters
    • C08L33/14Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/04Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C08L39/06Homopolymers or copolymers of N-vinyl-pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Textile Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Artificial Filaments (AREA)
  • Nonwoven Fabrics (AREA)
  • Cosmetics (AREA)
RU2019126497A 2017-01-23 2018-01-22 Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества RU2019126497A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201770043 2017-01-23
DKPA201770043 2017-01-23
PCT/DK2018/050010 WO2018133910A1 (en) 2017-01-23 2018-01-22 Method for preparing electrospun fibers with a high content of a bioadhesive substance

Publications (2)

Publication Number Publication Date
RU2019126497A true RU2019126497A (ru) 2021-02-24
RU2019126497A3 RU2019126497A3 (cg-RX-API-DMAC7.html) 2021-05-26

Family

ID=58536695

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019126497A RU2019126497A (ru) 2017-01-23 2018-01-22 Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества

Country Status (14)

Country Link
US (1) US11045430B2 (cg-RX-API-DMAC7.html)
EP (1) EP3570822B1 (cg-RX-API-DMAC7.html)
JP (1) JP7353980B2 (cg-RX-API-DMAC7.html)
KR (1) KR102595001B1 (cg-RX-API-DMAC7.html)
CN (1) CN110290783A (cg-RX-API-DMAC7.html)
AU (1) AU2018209592B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019014732A2 (cg-RX-API-DMAC7.html)
CA (1) CA3050026A1 (cg-RX-API-DMAC7.html)
DK (1) DK3570822T3 (cg-RX-API-DMAC7.html)
ES (1) ES2874787T3 (cg-RX-API-DMAC7.html)
IL (1) IL268185B2 (cg-RX-API-DMAC7.html)
MX (1) MX387268B (cg-RX-API-DMAC7.html)
RU (1) RU2019126497A (cg-RX-API-DMAC7.html)
WO (1) WO2018133910A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201808743VA (en) * 2014-06-10 2018-11-29 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
BR112019014236A2 (pt) 2017-01-23 2020-03-17 Afyx Therapeutics A/S Método para a fabricação de um produto de duas camadas à base de fibras eletrofiadas
WO2021072113A1 (en) 2019-10-08 2021-04-15 Afyx Therapeutics A/S Compositions for the delivery of proteins
ES2876401B2 (es) * 2020-05-11 2024-04-05 Bioinicia S L Parches auto-adhesivos de fibras para la liberación controlada de bioactivos
EP4436544A1 (en) 2021-11-23 2024-10-02 Afyx Development A/S Mucosal patches and methods of use thereof
KR20240073700A (ko) 2022-11-18 2024-05-27 한국생산기술연구원 다공성 폴리 유산 미세섬유 및 이의 제조방법
WO2025051337A1 (en) 2023-09-06 2025-03-13 Afyx Development A/S Compositions and methods for treating and preventing oral cancer
KR20250066118A (ko) 2023-11-06 2025-05-13 한국생산기술연구원 두가지 기능성 물질이 담지된 다공성 셀룰로오스 아세테이트 섬유 구조체 및 이의 제조방법

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2134635Y (zh) 1992-08-18 1993-05-26 许竞新 具有连续响声的印刷鞭炮
DE4337152A1 (de) 1993-10-30 1995-05-04 Merck Patent Gmbh Verfahren zur Herstellung von wäßrigen Chitosan-Lösungen und -Gelen
US6753454B1 (en) 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor
IL150642A0 (en) 2000-01-28 2003-02-12 Smithkline Beecham Corp Electrospun pharmaceutical compositions
EP1372604A2 (en) 2001-03-22 2004-01-02 Battelle Memorial Institute Manufacturing dissolvable dosage forms
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7309498B2 (en) 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
US20030017208A1 (en) 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
TW200410714A (en) 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
AU2003265446A1 (en) 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
KR100564366B1 (ko) 2003-11-19 2006-04-07 재단법인서울대학교산학협력재단 나노 섬유형 부직포를 이용한 조직 재생용 차폐막 및 그의 제조 방법
JP4526851B2 (ja) 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
US8222166B2 (en) 2004-10-06 2012-07-17 The Research Foundation Of State University Of New York High flux and low fouling filtration media
US7390760B1 (en) 2004-11-02 2008-06-24 Kimberly-Clark Worldwide, Inc. Composite nanofiber materials and methods for making same
WO2006106514A2 (en) 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
US9011754B2 (en) 2006-12-05 2015-04-21 Nanyang Technological University Manufacturing three-dimensional scaffolds using electrospinning at low temperatures
JP2009041117A (ja) 2007-08-06 2009-02-26 Nisshinbo Ind Inc 多糖類ナノファイバー
US20100254961A1 (en) 2007-09-05 2010-10-07 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
WO2009120365A2 (en) 2008-03-27 2009-10-01 Agigma, Inc. Methods and compositions for the delivery of agents
US8361492B2 (en) 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
WO2010099292A2 (en) 2009-02-25 2010-09-02 North Carolina State University Biodegradable drug or other active delivery system
US20110111012A1 (en) 2009-11-12 2011-05-12 Hemcon Medical Technologies, Inc. Nanomaterial wound dressing assembly
US9808418B2 (en) 2010-11-26 2017-11-07 University Of The Witwatersrand, Johannesburg Pharmaceutical dosage form
CN102251317B (zh) * 2011-05-18 2013-01-16 东华大学 一种药物释放可控的电纺纤维的制备方法
WO2013165604A1 (en) 2012-05-02 2013-11-07 Massachusetts Institute Of Technology Electroprocessing of active pharmaceutical ingredients
WO2014066297A1 (en) 2012-10-22 2014-05-01 North Carolina State University Nonwoven fiber materials
US9393216B2 (en) 2012-11-06 2016-07-19 University Of Washington Through Its Center For Commercialization Vaginal matrices: nanofibers for contraception and prevention of HIV infection
EP2810645B1 (en) 2013-06-06 2017-05-24 A. Sezai Sarac New Drug Delivery System
EP2813212A1 (en) 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
CZ308492B6 (cs) 2013-10-25 2020-09-23 Contipro A.S. Kosmetická kompozice na bázi kyseliny hyaluronové, způsob její přípravy a použití
WO2015106342A1 (en) * 2014-01-15 2015-07-23 University Of Guelph Compositions and methods to encapsulate and control release of volatile organic compounds for increasing shelf-life of perishable products
EP3151872B1 (en) 2014-06-05 2018-12-12 University Of The Witwatersrand, Johannesburg Wound dressing
SG10201808743VA (en) 2014-06-10 2018-11-29 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
MX2017007417A (es) * 2014-12-12 2018-04-20 Univ Leland Stanford Junior Filtro de aire para captura de pm2.5 de alta eficiencia.
SG10201913222XA (en) * 2015-11-19 2020-03-30 Afyx Therapeutics As A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site

Also Published As

Publication number Publication date
EP3570822B1 (en) 2021-05-05
JP7353980B2 (ja) 2023-10-02
CN110290783A (zh) 2019-09-27
IL268185B1 (en) 2023-09-01
KR102595001B1 (ko) 2023-10-26
MX2019008155A (es) 2019-11-07
AU2018209592B2 (en) 2024-03-21
EP3570822A1 (en) 2019-11-27
AU2018209592A1 (en) 2019-07-25
US11045430B2 (en) 2021-06-29
WO2018133910A1 (en) 2018-07-26
CA3050026A1 (en) 2018-07-26
US20190254986A1 (en) 2019-08-22
MX387268B (es) 2025-03-18
ES2874787T3 (es) 2021-11-05
RU2019126497A3 (cg-RX-API-DMAC7.html) 2021-05-26
DK3570822T3 (da) 2021-07-26
BR112019014732A2 (pt) 2020-03-10
IL268185B2 (en) 2024-01-01
NZ755185A (en) 2025-06-27
IL268185A (en) 2019-09-26
JP2020506307A (ja) 2020-02-27
KR20190126306A (ko) 2019-11-11

Similar Documents

Publication Publication Date Title
RU2019126497A (ru) Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества
RU2016151163A (ru) Композиции, включающие электрогидродинамически полученные волокна, для нанесения заданных доз активного вещества на кожу или слизистую оболочку
JP2020506307A5 (cg-RX-API-DMAC7.html)
Meka et al. A comprehensive review on polyelectrolyte complexes
JP5912126B2 (ja) 医薬投与形態
CN102178640B (zh) 将疏水性药物均匀负载于亲水性聚合物电纺纳米纤维的方法
Su et al. Fabrication of the polyphosphates patched cellulose sulfate-chitosan hydrochloride microcapsules and as vehicles for sustained drug release
US8815283B2 (en) Immuno-compatible hydrogel system
Wang et al. Preparation, characterization and applications of low-molecular-weight alginate–oligochitosan nanocapsules
Wang et al. Alginate/polyethylene glycol blend fibers and their properties for drug controlled release
Fredrick et al. Synthesis and characterization of polysaccharide hydrogel based on hydrophobic interactions
CN107675364B (zh) 以乳液电纺技术制备双载药复合纤维膜的方法
CN101280467A (zh) 一种壳聚糖基纳米纤维的制备方法与应用
CN103073730B (zh) CA-(PLA-ran-PCL)-b-PEG嵌段共聚物及其制备方法与应用
CN104894856B (zh) 一种提升丝素蛋白纳米纤维力学性能的处理方法
Salazar-Brann et al. Electrospinning of chitosan from different acid solutions
CN103381146B (zh) 双层缓控释纳米粒及其制备方法和应用
Elzatahry et al. Evaluation of alginate–chitosan bioadhesive beads as a drug delivery system for the controlled release of theophylline
Potaś et al. The Potential of polyelectrolyte multilayer films as drug delivery materials
Mikušová et al. Comparative study of polysaccharide-based hydrogels: Rheological and texture properties and ibuprofen release
CN105694399A (zh) 一种仿病毒结构高分子囊泡及其制备方法与应用
Penchev et al. Novel electrospun nanofibers composed of polyelectrolyte complexes
Özemre et al. Preparation of nanodelivery systems for oral administration of low molecular weight heparin
CN106466300A (zh) 一种装载难溶性药物的复合壳聚糖纳米粒制剂及其制备方法和应用
CN108771659B (zh) 一种吲哚箐绿荧光示踪的反式茴香脑-白蛋白纳米颗粒的制备方法